Lexington Biosciences Commences Trading on Canadian Securities Exchange (CSE: LNB)

VANCOUVER, BC–(May 9, 2017) –  Lexington Biosciences, Inc. (CSE: LNB)  (the “Company” or “Lexington“), a development-stage medical device company operating within the healthcare industry, is pleased to announce that the Company has commenced trading on the Canadian Securities Exchange (the “Exchange“) effective May 9, 2017 under the symbol “LNB.” Transaction and Private Placement The Company

Read More

What’s the No. 1 killer of Americans?

Story highlight Heart disease and cancer are the top two killers of Americans (CNN)The leading causes of death remained the same from the year before: Heart disease is the No. 1 killer, followed by cancer, according to the U.S. Centers for Disease Control and Prevention, and infant mortality decreased 2.3%. But there is good news

Read More

1 3 4 5



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News